Results 181 to 190 of about 66,822 (310)

Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment

International Journal of Cancer, Volume 158, Issue 3, Page 633-641, 1 February 2026.
What's new? Although human epidermal growth factor 2‐positive (HER2+) breast cancer is an aggressive malignancy, significant survival benefits are possible with targeted anti‐HER2 therapies. Whether these therapies are used as recommended, however, is unknown. Here, the authors investigated data from population‐based registries in Norway to assess anti‐
Kathrine F. Vandraas, Sarah Hjorth, Cassia B. Trewin‐Nybråten, Giske Ursin, Edoardo Botteri, Bettina Kulle Andreassen, Kristin V. Reinertsen, Egil S. Blix, Bjørn Naume, Nathalie C. Støer   +9 more
wiley   +1 more source

Atypical Femur Fractures Without Bisphosphonate Exposure (AFFwB): A Retrospective Report of 21 Cases. [PDF]

J Clin Med
Lucchetta L, Ruggiero C, Berardi S, Franceschi A, Bisaccia M, Rinonapoli G.   +5 more
europepmc   +1 more source

Severe osteonecrosis of the jaws in a compromised patient subjected to bisphosphonate therapy

, 2014
Juliana Dreyer da Silva de Menezes, Nicole Mello Rahde, Fernanda Gonçalves Salum, Maria Antonia Zancanaro de Figueiredo, Karen Cherubini   +4 more
openalex   +1 more source

Intravesical oxybutynin for bladder capacity in children with spina bifida: the ‘Place de l’OXybutynine Intravésicale chez le Patient Enfant Neurologique’ (POXIPEN) trial protocol

BJU International, Volume 137, Issue 2, Page 390-398, February 2026.
Background Neurogenic bladder is defined as a dysfunction of the bladder resulting from damage to the central or peripheral nervous systems. Its treatment is based on a progressive therapeutic escalation, rapidly involving invasive therapeutic procedures such as repeated intradetrusor injections and surgery.
Marie Buzzi, Jonathan Epstein, Zahi Hatem, Nadine Juge, Charles Mazeaud, Jean‐Louis Lemelle, Nicolas Berte   +6 more
wiley   +1 more source

High Prevalence of Osteopenia and Osteoporosis in Total Hip and Total Knee Arthroplasty Patients and Effects of Anti-Resorptive Agents on Bone Health Optimization: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Wong RMY, Wong PY, Lee JK, Unnanuntana A, Amphansap T, Ebeling PR, Close J, Duque G, Law SW, Cheung WH.   +9 more
europepmc   +1 more source

Drug-Induced Dental Caries, Lessons from a Disproportionality Analysis in Vigibase®: Beware of Bisphosphonates, Atropinic, Immunosuppressant and Hyperglycaemic Drugs [PDF]

, 2017
Emilie Patras de Campaigno, Inès Kebir, Maryse Lapeyre‐Mestre, Jean‐Louis Montastruc, Fabien Despas   +4 more
openalex   +1 more source

Avascular Necrosis and Minimal Trauma Fractures in Telomere Biology Disorders

Clinical Genetics, Volume 109, Issue 2, Page 286-293, February 2026.
Avascular Necrosis (AVN) and Minimal Trauma Fractures (MTF) cause significant morbidity in people with Telomere Biology Disorders (TBDs). They occur more frequently in young patients and in those with autosomal recessive (AR) or X‐linked recessive (XLR) than in autosomal dominant (AD) genotypes.
Arman M. Niknafs, Neelam Giri, Marena R. Niewisch, Sharon A. Savage   +3 more
wiley   +1 more source

Bisphosphonate Therapy and the Occurrence of the Hungry Bone Syndrome After Surgery for Primary Hyperparathyroidism. [PDF]

Int J Endocrinol
Etemadi R, Mansouri A, Salehidoost R, Tabatabaei ET.   +3 more
europepmc   +1 more source

Isolated Atypical Pedicle Stress Fractures in Patients on Prolonged Bisphosphonate Therapy: Report of Two Cases and a Literature-Based Proposal for Diagnostic Criteria. [PDF]

J Clin Med
Auron M, Fisher-Negev T, Barkay G, Schroeder JE.   +3 more
europepmc   +1 more source

Skeletal distribution of bisphosphonate after elution from porous implants

, 2010
Kimberly McKenzie
openalex   +1 more source